NCT04294212 (IMGEPR) is a clinical trial in Medical Termination of Pregnancy, sponsored by University Hospital, Brest.

Who is sponsoring NCT04294212?

NCT04294212 is sponsored by University Hospital, Brest.

What condition does NCT04294212 study?

NCT04294212 studies Medical Termination of Pregnancy.

Is NCT04294212 still recruiting?

NCT04294212 is currently status unknown. Last updated 4 March 2020.

Last reviewed 2020-03-04 · How we verify

NCT04294212: IMGEPR

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Medical Termination of Pregnancy : Evaluation of Patients' Practices and Feelings in Brest Hospital

Status unknown Last updated 4 March 2020

What this trial tests

trial in Medical Termination of Pregnancy in 150 participants. Status unknown.

Timeline

10 February 2020

Primary endpoint
10 August 2020

10 August 2020

Quick facts

Lead sponsor	University Hospital, Brest
Status	Status unknown
Study type	OBSERVATIONAL
Enrollment	150
Start date	10 February 2020
Primary completion	10 August 2020
Estimated completion	10 August 2020
Sites	1 location across France

Conditions studied

Medical Termination of Pregnancy — all drugs for Medical Termination of Pregnancy →

Sponsor

University Hospital, Brest

Who can join

Eligibility, female only, with Medical Termination of Pregnancy. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study evaluate the feelings of patients about a medical termination of pregnancy that they experienced in Brest Hospital. Patients responded to an online questionnaire assessing their feelings at each stage of the medical termination process. Their answers were associated with their medical data.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other University Hospital, Brest trials

Trials by the same sponsor.

NCT07526688 — Aerobic Physical Activity and Orofacial Myofascial Pain · NA · not yet recruiting
NCT07487155 — Unified Junction of Care, Integrated Treatments and Team Coordination for ADHD in Prison Settings With Substance Use Dis · NA · not yet recruiting
NCT07417605 — Diagnostic Performance Of 4D Dynamic LAFOV FDG-PET Acquisition for Differentiation of Residual Disease and Post-radiatio · not yet recruiting
NCT07302074 — Understanding of Rare Inflammatory Arthritis in Comparison to Classical Inflammatory Arthritis : Tissular Observations a · NA · recruiting
NCT06441773 — Impact of Respiratory Rehabilitation on Quality of Life in Patients With Metastatic Non-small Cell Lung Cancer Treated W · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04294212 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University Hospital, Brest
Last refreshed: 4 March 2020

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04294212.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing